相关实验视频

Updated: Jun 13, 2025

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Published on: June 21, 2024

抗纤维素药对COVID-19后肺部瘤的影响

Yosri Mohamed Kamel Akl¹, Youssef Amin Soliman¹, Sabah Ahmed Mohamed¹

¹Faculty of Medicine, Cairo University.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

|June 12, 2025

概括

后COVID肺部问题可能会持续,三分之一的患者显示持久的网膜. 抗纤维素治疗,如皮尔芬尼,对这些持续的肺部异常有适度的影响.

科学领域:

肺部病理学肺部病理学
传染性疾病传染性疾病
放射学放射学是一门学科.

背景情况:

COVID-19可能会导致急性和持续的呼吸系统问题,导致长期功能障碍.
间歇性肺部异常是后急性COVID-19综合征的一个重大问题.
包括皮尔芬尼在内的抗纤维菌药物正在研究治疗这些肺部继发症.

研究的目的:

为了评估COVID-19感染后的临床和放射性肺部异常.
评估抗纤维素治疗对这些后COVID肺部异常的解决影响.
识别持续性肺部变化的模式,这些变化可能会为未来的治疗策略提供信息.

主要方法:

在90名COVID-19患者的回顾性观察研究中,诊断后6个月的随访时间为6个月.
收集人口统计数据,并发症,运动耐受性和连续胸部计算机断层扫描 (CT) 扫描.
分析1个月和6个月CT发现,以追踪肺部异常和CT得分的变化.

主要成果:

一个月后的初始CT扫描显示了高水平的地面玻璃不透明度 (87.8%) 和网状 (43.3%).
6个月后,33.3%的患者恢复正常,而41%的患者有持续的网膜和22.2%的患者有持续的地面玻璃不透明.
CT得分在6个月内显著改善,但CT得分变化与非标签的皮尔芬尼使用之间没有显著的相关性.

结论:

抗纤维素疗法对改善COVID后肺部问题的适度效果有所证明.
在三分之一的患者中观察到持久的网络,突出显示了未来干预的潜在目标.
了解持续的放射性异常对于指导后续治疗决策在后COVID肺部疾病至关重要.

更多相关视频

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

相关概念视频

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.